Stockwinners Market Radar for November 22, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:04 EST Cathie Wood's ARK Investment bought 59K shares of Teladoc today

18:47 EST Meta Platforms CEO Zuckerberg sells $9.5M in two separate transactions - In regulatory filings, Meta Platforms disclosed that its CEO Mark Zuckerberg sold $9.5M in each of two separate transactions as part of an option expiry on November 20th and November 21st.

18:14 EST Sprouts Farmers Market CEO sells $2.5M in common stock - In a regulatory filing, Sprouts Farmers Market disclosed that its CEO sold 61K shares of common stock on November 21st in a total transaction size of $2.5M.

17:48 EST 3D Systems director buys $228.4K in common stock - In a regulatory filing, 3D Systems disclosed that its director Thomas Erickson bought 50K shares of common stock on November 21st in a total transaction size of $228.4K.

17:33 EST COMSovereign Holding receives additional Nasdaq non-compliance notice - COMSovereign Holding received an additional notice of non-compliance from the Nasdaq Listing Qualifications Staff given that, in addition to the Form 10-K for the year ended December 31, 2022, and the Forms 10-Q for the periods ended March 31, 2023 and June 30, 2023, the company has not yet filed its Form 10-Q for the period ending September 30, 2023 with the SEC. The company previously requested and was granted a hearing before the Nasdaq Hearings Panel, at which it will present its plan to regain compliance with the filing requirement, as well as a further stay of any additional action by Nasdaq pending the issuance of the Panel's decision and the expiration of any extension the Panel may grant to the company following the hearing.

17:18 EST Methanex reports outage at Egypt methanol facility - Methanex's 1.26 million ton Egypt methanol production facility - Methanex 50% equity interest of 0.63 million tons per annum - was impacted by an unplanned outage in mid-October caused by a mechanical failure in the synthesis gas compressor. The unit has since been removed from service and is currently being repaired on an expedited schedule at the manufacturer overseas. The company currently estimates that production will resume towards the end of Q1 2024

16:30 EST Coinbase Chairman armstrong sells over $480K in company shares - The chairman of Coinbase Brian Armstrong, disclosed in a filing, the sale of 4,625 shares of company stock at $103.92 per share on November 20, for a total transaction amount of $480,639.

16:17 EST Banc of California, PacWest Bancorp receive shareholder approvals for merger - Banc of California (BANC) and PacWest Bancorp (PACW) jointly announced that, at their respective special meetings of stockholders held earlier today, they each received the necessary stockholder approval for the proposed combination of Banc of California and PacWest. The final results for the proposals voted on at the special meetings of each company's stockholders held today will be set forth in the companies' separate Current Reports on Form 8-K to be filed with the U.S. SEC. The transaction is expected to close as planned on or around November 30, 2023, subject to the satisfaction of certain closing conditions.

16:16 EST DoorDash COO sells $1.69M in common stock - In a regulatory filing, DoorDash disclosed that its COO Prabir Adarkar sold 17.8K shares of common stock on November 20th in a total transaction size of $1.69M.

16:09 EST Nasdaq sends notice of non-compliance to Agrify for not timely filing of 10-Q - Agrify Corporation announced that on November 16 it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying Agrify that it was not in compliance with requirements of Nasdaq Listing Rule 5250c1as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30 with the Securities and Exchange Commission.This notification has no immediate effect on the listing of Agrify's common stock on the Nasdaq. However, if Agrify fails to timely regain compliance with the Listing Rule, Agrify's common stock will be subject to delisting from Nasdaq. As disclosed in the Current Report on Form 8-K filed by the Company on April 17 Agrify's audit committee concluded that, as a result of errors in the accounting for warrants previously issued by Agrify, it is appropriate to restate Agrify's previously issued unaudited condensed consolidated financial statements as of and for the fiscal periods ended March 31, 2022, June 30, 2022 and September 30, 2022 in amended quarterly reports for the affected periods. Agrify filed amended Forms 10-Q with those restated financial statements on October 2 . However, given the timeline for the process to prepare the amended quarterly reports, Agrify was unable to complete and file its Form 10-K for the fiscal year ended December 31, 2022..

15:49 EST Stellantis to repurchase 50M common shares from Dongfeng - Stellantis and a subsidiary of Dongfeng Motor Group Company Limited confirm they have executed a transaction in which Stellantis will repurchase 50M common shares, or 1.58% of Stellantis' share capital pre-cancellation, from Dongfeng, for a total consideration of EUR 934M. Stellantis plans to cancel these shares. "In accordance with the terms of the previously announced share repurchase framework agreed by the two parties on July 15, 2022, Dongfeng submitted an offer to sell to Stellantis specifying both the number of shares and the potential transaction timing, and Stellantis exercised its right to accept the offer. Per the pre-agreed terms of the share repurchase framework, pricing was set at the five-day average closing price of Stellantis shares on Euronext Milan for the period ending immediately prior to the date on which Dongfeng submitted an offer, which was on November 21. Dongfeng will retain 49.2M common shares, representing 1.58% of Stellantis' share capital post-cancellation, and the share repurchase framework agreed between the two parties remains in place with respect to such shares. The purchase of Stellantis common shares by Stellantis from Dongfeng was carried out under the authority granted by Stellantis' general meeting of April 13, 2023. The share repurchase transaction with Dongfeng will not impact Stellantis' EUR 1.5B open-market share repurchase program announced February 22, 2023, which is expected to complete by the end of 2023," the company said.

15:39 EST Bragg Gaming jumps 25% after investor Raper Capital asks for 3rd party sale - Shares of Bragg Gaming are up 25% or $1.13 per share on Wednesday to approximately $5.72 after Jeremy Raper, head of Raper Capital, beneficially owning 375K hares of Bragg Gaming Group, sent a letter to to Bragg CEO and Chairman Matevz Mazij, asking the company to consider strategic alternatives, including a possible sale. The letter said in part: "In the almost five full years since the transformational Oryx acquisition, Bragg has grown evenues by almost 4x rom 26mm EUR to 97mm EUR nd Adjusted EBITDA by 14x from 1.2mm EUR to 16.5mm EUR . And yet despite this impressive record of both top- and bottomline growth, the stock price is somehow 25% lower now than then! This chronic underperformance has occurred, mind you, in spite of Bragg achieving a NASDAQ uplisting in 2021 - an event heralded at the time as the solution to our Company's persistent valuation discount. Suffice to say, the public markets have had plenty of opportunity to appraise our Company's growth story, over time, and yet the record demonstrates that it will not, or cor cannot, accord even the lower bounds of what most shareholders would consider fair value.A sale of the company should deliver a gargantuan premium, and certainty of value. As such, it is evidently clear that a third-party sale of the business is the only way to crystallize a proper return for the underlying business value that you, and legacy management, have created." Reference Link

14:39 EST Volkswagen offers 11% pay raise for Chattanooga production employees - Volkswagen of America announces an 11% pay raise for its Chattanooga assembly plant's production team members. "The increase is effective starting in December and a compressed wage progression timeline begins in February. Volkswagen of America annually evaluates compensation for our production team members at the end of the year to ensure we continue to offer a competitive and robust compensation package designed to attract and motivate employees who make our daily operations possible at the plant," the company stated. Reference Link

14:26 EST National Labor Relations Board says Apple kept benefits from Towson, MD store - "The National Labor Relations Board or NLRB, has issued a Complaint on the Unfair Labor Practice charge against Apple. The charge, filed by the International Association of Machinists and Aerospace Workers' ,IAM Coalition of Organized Retail Employees or IAM CORE, alleges that the Towson, MD Apple employees were unlawfully denied new benefits offered to other Apple employees nationwide at the beginning of 2023. At the heart of the matter was Apple's deviation from prior practices of including Towson employees in corporate-wide enhancements after consultation with the union. IAM CORE initially expressed its disappointment in a letter addressed to Apple CEO Tim Cook, urging the company to reconsider its decision and adhere to established protocols. The NLRB's decision to issue a Complaint reflects the NLRB's determination that sufficient evidence supports the charge to merit further prosecution. "The issuance of this Complaint will advance the principles of fairness and equality in the workplace," said IAM Eastern Territory General Vice President David Sullivan," said the NLRB in a statement. Reference Link

13:53 EST North American rail traffic up 2.8% for the week ending November 18 - The Association of American Railroads or AAR, reported U.S. rail traffic for the week ending November 18. For this week, total U.S. weekly rail traffic was 501,416 carloads and intermodal units, up 4% compared with the same week last year. Total carloads for the week ending November 18 were 237,416 carloads, up 3.8 %compared with the same week in 2022, while U.S. weekly intermodal volume was 264,000 containers and trailers, up 4.1% compared to 2022. Seven of the 10 carload commodity groups posted an increase compared with the same week in 2022. They included coal, up 3,185 carloads, to 69,630; chemicals, up 2,519 carloads, to 32,295; and motor vehicles and parts, up 1,632 carloads, to 15,260. Commodity groups that posted decreases compared with the same week in 2022 were grain, down 475 carloads, to 24,483; miscellaneous carloads, down 442 carloads, to 7,588; and metallic ores and metals, down 68 carloads, to 20,837. North American rail volume for the week ending November 18 on 12 reporting U.S., Canadian and Mexican railroads totaled 351,368 carloads, up 3.8% compared with the same week last year, and 343,001 intermodal units, up 1.7% compared with last year. Total combined weekly rail traffic in North America was 694,369 carloads and intermodal units, up 2.8 %... North American rail volume for the first 46 weeks of 2023 was 30,221,325 carloads and intermodal units, down 3.1% compared with 2022...Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific Kansas City (CP), Kansas City Southern (KSU), Norfolk Southern (NSC),Union Pacific (UNP), Greenbrier (GBX),Trinity Industries (TRN), Wabtec (WAB), FreightCar America (RAIL), and Rail Vision (RVSN). Reference Link

13:39 EST Hongli Group Inc trading resumes

13:15 EST Advent Technologies gets 180-day extension by Nasdaq for compliance - Advent Technologies announced that it has received a notification letter from Nasdaq Stock Market that the company has been granted an additional 180-day compliance period, or until May 20, 2024, to regain compliance with Nasdaq's minimum bid price rule. If at any time before May 20, 2024, the closing bid price of the company's ordinary shares is at least $1.00 per share for a minimum of 10 consecutive business days, the company will regain compliance with this Nasdaq rule and this matter will be closed. This current notification from Nasdaq has no immediate effect on the listing or trading of the company's ordinary shares, which will continue to trade on Nasdaq under the symbol "ADN," the company noted.

13:14 EST Baker Hughes reports U.S. rig count up 4 to 622 rigs - Baker Hughes reports that the U.S. rig count is up 4 from last week to 622 with oil rigs unchanged at 500, gas rigs up 3 to 117 and miscellaneous rigs up 1 to 5. The U.S. Rig Count is down 162 rigs from last year's count of 784 with oil rigs down 127, gas rigs down 38 and miscellaneous up 3. The U.S. Offshore Rig Count is up 2 to 21, up 4 year-over-year. The Canada Rig Count is up 1 from last week to 197, with oil rigs up 1 to 124, and gas rigs unchanged at 73. The Canada Rig Count is up 3 from last year's count of 194, with oil rigs down 5, and gas rigs up 8.

13:05 EST Textron reports agreement to purchase 48 Cessna Skyhawks to support BAA Training - Textron Aviation announced an agreement with BAA Training for the purchase of 48 Cessna Skyhawk aircraft, expected to be delivered in 2026. The deal, inked at the Dubai Airshow, substantially expands BAA Training's existing fleet, offering increased capacity for students, streamlining the flight training process and ensuring an overall enhanced student experience, the company said in a statement. The Cessna Skyhawk is designed and manufactured by Textron Aviation.

12:51 EST Safety Shot says preparing lawsuit against short sellers - Safety Shot says "it has come to our attention that there are several disclosed short sellers publishing malicious defamatory, inaccurate articles about Safety Shot and its management in a willful attempt to scare SHOT investors out of their positions in hopes of getting them to sell their shares so they can then buy at a lower cost to cover their disclosed short position." Several of these groups are currently being sued in federal court for "publishing these fraudulent articles on other companies," says the company, which adds that it "will be preparing a similar lawsuit against these Cayman Island based individuals." Brian John, CEO, stated: "I encourage anyone, including the people writing these defamatory articles, to come to one of our events or to our corporate offices in Jupiter Florida to test Safety Shot for themselves. I also encourage all investors to do their own due diligence on our product and our company. I have personally given Safety Shot to thousands of people now and get the same response from everyone, they can't believe it works. This is why we do and will continue to do events all over because trying Safety Shot is believing in Safety Shot."

12:31 EST Broadway reports notification from Nasdaq regarding delinquent Form 10-Q - Broadway Financial Corporation announced that it received a letter from the Nasdaq Stock Market LLC, dated November 16, 2023, informing the company that it no longer complies with Nasdaq Listing Rule 5250(c)(1) because Broadway has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023. Under Nasdaq's Listing Rules, the company must submit a plan to regain compliance to Nasdaq within 60 calendar days of the date of the letter. If Broadway's plan is accepted, then Nasdaq may grant an exception of up to 180 calendar days from the original due date of the Form 10-Q. Separately, on November 15, 2023, the company received a letter from Nasdaq confirming that Broadway had regained compliance with the minimum bid price requirements under Nasdaq Listing Rule 5550(a)(2) for maintaining its listing on The Nasdaq Capital Market.

12:00 EST Guess falls -7.8% - Guess is down -7.8%, or -$1.86 to $21.86.

12:00 EST Studio City rises 7.5% - Studio City is up 7.5%, or 34c to $4.86.

12:00 EST Jumia Technologies rises 11.6% - Jumia Technologies is up 11.6%, or 33c to $3.18.

10:24 EST Deere: Pricing caught up with inflation, supply chains reverted to normal in Q4

10:11 EST Deere: Construction, Forestry market demand outlook remains mixed - Sees uncertainty in housing and commercial investments. Comments taken from Q4 earnings conference call.

10:00 EST Universal Compression falls -7.7% - Universal Compression is down -7.7%, or -$2.35 to $28.22.

10:00 EST Hims & Hers rises 9.0% - Hims & Hers is up 9.0%, or 69c to $8.27.

10:00 EST Beachbody Company rises 4643.2% - Beachbody Company is up 4643.2%, or $6.96 to $7.11.

09:47 EST Precision Auto Care, Inc falls -7.1% - Precision Auto Care, Inc is down -7.1%, or -77c to $10.05.

09:47 EST Guess falls -12.4% - Guess is down -12.4%, or -$2.95 to $20.77.

09:47 EST Scor ADR rises 8.5% - Scor ADR is up 8.5%, or $1.55 to $19.86.

09:41 EST Cal-Maine Foods continues to assess options for appeal of recent court decision - Cal-Maine Foods issued the following statement: "Approximately 20 years ago, Cal-Maine Foods along with many other fresh egg producers in the United States, responded to growing demands from consumers and retailers to improve the overall treatment of egg laying hens. These programs were in line with other prevailing animal welfare laws across the protein industry and were not intended to restrict supply and affect prices. The programs were supported by our customers and form the basis of many state laws across the country today. On November 21, 2023, a jury found that defendants, including Cal-Maine Foods, Inc., were liable for an alleged conspiracy to inflate egg product prices in the case Kraft Foods Global, Inc. et al. v. United Egg Producers, Inc. et al., Case No. 1:11-cv-8808 in the U.S. District Court for the Northern District of Illinois. The damages phase of the trial is scheduled to take place on November 28 and 29, 2023. While we are disappointed with the overall decision, we prevailed on a number of issues that we believe are important and should ultimately define this case. The plaintiffs alleged a conspiracy running from 1998-2008 with damages extending through 2012. The court and jury determined that any alleged damages would be limited to the period 2004-2008. The jury also rejected other key portions of the plaintiffs' case that we believe should limit the plaintiffs' damages request further. Cal-Maine Foods will vigorously contest plaintiffs' presentation of purported damages and will continue to assess the decision and options for appeal."

09:35 EST Northwest Biotherapeutics provides update on final preparations for MAA - Northwest Biotherapeutics provided an update about the final preparations for the Marketing Authorization Application that will be submitted to the Medicines and Healthcare Products Regulatory Agency in the U.K. for commercial approval of the Company's DCVax-L treatment for glioblastoma. The Company previously reported that one key section of the MAA package remained to be completed and to then be delivered to an independent publisher for quality control checking of citations, numbers, cross-references, formatting and the like, in preparation for the submission. The Company provided an update that most of the work has been completed on the key section of the MAA that remained to be done at the time of the prior update, as well as on required supporting documents, the majority of which have been delivered to the publisher/QC team. That team is now under way on this final stage of their work. As described in the Company's prior update, it is anticipated that the publisher/QC team will need several weeks to complete their work on both the last portion of the MAA package and the integrated whole. Their work is independent of the Company.

09:32 EST Cineverse signs new agreement with Little Dot Studios - Cineverse announced that the company has signed a new agreement with Little Dot Studios to manage and grow a handful of their owned & operated OTT channels. In this new deal, Fandor, RetroCrush, and Midnight Pulp will now be exclusively marketed and managed on YouTube by Little Dot Studios. All of the channels are owned and operated by Cineverse and powered by the company's digital managed service tech, Matchpoint, to streamline delivery. Collectively, the service has seen over 12M lifetime views.

09:19 EST TOP Ships announces extension of time charter employment for two VLCC tankers - TOP Ships has agreed to extend the time charter employment contracts of its two VLCC vessels, M/T Julius Caesar and M/T Legio X Equestris, at an increased rate. Specifically, the firm period will be extended for approximately 3 years at a daily rate of $41,500 per vessel with two additional years at the charterer's option.

09:14 EST ImmunoPrecise's BioStrand launches RAG-based LLM platform - ImmunoPrecise Antibodies announced that its subsidiary, BioStrand has launched an advanced Retrieval Augmented Generation-based Large Language Model platform. This breakthrough platform seamlessly integrates with the company's patented HYFT technology and LENSai platform, and the company reports that it is designed for unprecedented accuracy, interpretability and data-centric design in generative AI tools.

09:09 EST CNS Pharmaceuticals presents updated safety data from berubicin study - CNS Pharmaceuticals announced the presentation of updated safety data from the ongoing potentially pivotal study evaluating Berubicin, the Company's novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier, in a poster presentation at the SNO 28th Annual Meeting, held November 15-19, 2023 in Vancouver, Canada. Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals presented the poster, which was titled, "A randomized, controlled trial of Berubicin vs. Lomustine after first-line therapy for glioblastoma multiforme: Interim Results." The poster is now available on the Company's website. The data presented at the SNO Annual Meeting show the comparability of the patient demographics in the two arms of the study, and of the safety data for each therapeutic modality in treating recurrent GBM. Patient demographics are comparable between each arm, including age, gender, race, body surface area, and Karnofsky Performance Status Scale. In addition, patients with unmethylated MGMT comprise approximately 40% of each arm, allowing for comparison irrespective of the molecular profile that might influence the efficacy of the therapy administered. Although more patients withdrew from the study in the Lomustine arm than the Berubicin arm, there are too few patients to reach any conclusion about whether this will affect the outcome. All reported adverse events for both arms are shown for all grades and grades 3-5. These were similar, including the more severe events in the higher grades. The adverse events occurring in more than 10% of patients and/or that were considered treatment-related, are shown for all grades as well as grades 3-5, and overall were relatively similar in the Berubicin and Lomustine arms. In terms of myelosuppression, there is no significant difference between the therapeutic arms, although thrombocytopenia appears to be slightly greater with Lomustine for all grades of severity as well as grades 3-5. The primary endpoint of the study is Overall Survival, a rigorous endpoint the FDA has recognized as the basis for approval of oncology drugs when a statistically significant improvement can be shown relative to a randomized control arm. As previously announced, CNS Pharmaceuticals has reached the criteria required by the study protocol to conduct a pre-planned, non-binding futility analysis, which an independent Data Safety Monitoring Board will review to determine whether or not to recommend continuing the study. CNS Pharmaceuticals previously reported that the Company would conduct this analysis after at least 50% of the patients in the population to be analyzed for the interim analysis had reached the primary efficacy endpoint, as provided for in the study protocol. The DSMB will review the number of deaths in each arm to ensure that the overall survival of patients receiving Berubicin shows at least a statistically significant comparability to those receiving Lomustine. The Company expects to release the conclusion of the DSMB before year end.

09:07 EST Agape ATP announces $1M share repurchase plan - AGAPE ATP announced that its board of directors has authorized a share repurchase plan under which the Company may repurchase up to $1M of its shares over the next 6 months. The board of directors have also approved the appointment of Network 1 Financial Securities as the broker to execute the repurchase on behalf of ATPC.

09:05 EST NanoXplore unveils large-scale dry process for manufacturing of graphene - NanoXploreannounces an interesting achievement in graphite exfoliation with the successful development of a novel dry graphene manufacturing process. The dry process centers on an advanced exfoliation technology with innovative media that enables high yield exfoliation without the introduction of impurities. The fusion of NanoXplore's strong intellectual property portfolio and the strategic patents acquisition of XG Sciences has yielded in this significant advancement in graphene production. The amalgamation of eight different patents registered and/or granted in Australia, Canada, United States, Taiwan, China, and South Korea together with NanoXplore's knowledge and experience deliver a graphene with a mix of performance and cost-effectiveness. The research and development related to this process started a decade ago with an investment of nearly $40M to date by NanoXplore and XG Sciences. NanoXplore's novel dry graphene manufacturing process has several benefits compared to the traditional liquid exfoliation methods. In terms of capital expenditures, dry manufacturing process delivers nearly 50% reduction versus liquid exfoliation process. According to the Corporation's current estimation, a net 8 000 metric tons capacity requires only $20M in capital expenditures, with a quarter of the current square footage required as opposed to liquid exfoliation process. NanoXplore has secured key suppliers, ensuring a robust supply chain for the main equipment. Equipment procurement is streamlined with off-the-shelf solutions, with an estimated lead time of 8-12 months. The Corporation is planning to start purchasing the equipment during 2024 calendar year. NanoXplore's novel dry graphene manufacturing process could bring the Corporation within cost parity with traditional carbon additives such as carbon black. The cost reduction results primarily from using low grade waste graphite as feedstock. Furthermore, it is highly scalable and operates on a continuous basis, streamlining production efficiency. Superior processability and long-term performance of dry-processed graphene offers investors a more attractive proposition and will expand the Corporation's total addressable market and accelerates commercial adoption of graphene. With granted patents already secured, this proprietary technology boosts some key physical properties in polymers by 20% compared to existing products for applications with over 20-yr longevity requirements. The technology finds potential applications in batteries and lightweight composites, enhancing its appeal in cutting-edge industries. This new manufacturing process also opens doors to a myriad of applications, including plastic pipes, geosynthetics, recycled plastics, concrete, drilling fluids, and insulation foams, among others. The new dry manufacturing process marks a paradigm shift, substantially reducing the environmental footprint associated with traditional graphite exfoliation methods. This new process addresses environmental concerns associated with water usage, eliminating washing and drying steps that contribute to increased costs and environmental impact.

09:04 EST Sapphiros announces distribution agreement with Cencora - Sapphiros announce it has entered into a distribution agreement with Cencora, formerly AmerisourceBergen Corporation. Under the agreement, Cencora will distribute the Sapphiros GoToKnow COVID-19 Antigen Rapid Tests to pharmacies across the United States. This strategic partnership promises to enhance accessibility and convenience for those seeking reliable COVID-19 testing solutions nationwide. In the future, Cencora will also have access to the future Sapphiros technologies including a fully disposable, low-cost multiplexed molecular diagnostics platform, additional rapid lateral flow tests for diseases beyond COVID-19 and the Satio novel blood collection patch coming in early 2024.

09:03 EST Allegiant Travel reports October total system passengers up 12.7% y-o-y - Allegiant Travel reported preliminary passenger traffic results for October. Total system passengers were up 12.7% to 1,407,936; available seat miles were up 13.3%; Departures were up 14.4% to 10,336; and average stage length was down 1.2% to 859.

08:54 EST DLocal CFO to step down to pursue new opportunities - As part of the company's Q3 results yesterday evening, co-CEO Pedro Arnt stated: "I would like to share that our CFO, Diego Cabrera Canay, has decided to step down from his position to pursue new opportunities. Diego has played a significant role in our financial success during his period at dLocal. He will stay on through Q1 of next year to ensure a smooth transition. As one executive leaves, we are also strengthening our team with new hires in senior positions, incorporating a new Principal Accounting Officer as well as an SVP of Government Relations and Strategic Partnerships."

08:40 EST Evolv appoints Courtney Cunnane as chief marketing officer - Evolv Technology announced the appointment of Courtney Cunnane as chief marketing officer, effective November 20.

08:32 EST Environmental Solutions CEO acquires 191,348 shares of company - Environmental Solutions Group Holdings announced that its Chairman and CEO Mr. Leng Chuang, Quek, has recently acquired 191,348 ordinary shares of the Company. These transactions, consisting of negotiated private block trades, were executed at an average price of US$0.50 per share. As a result of these acquisitions, Mr. Quek's ownership stake in ESGL will increase from 29.8% to 31.31%.

08:31 EST Broadcom completes acquisition of VMware - Broadcom (AVGO) announced that it has completed its acquisition of VMware (VMW). VMware's common stock will now cease to be traded on the New York Stock Exchange.

08:17 EST Salesforce reports Chairman and CEO Benioff sells 15,000 shares - In a regulatory filing, Salesforce said Chairman and CEO Marc Benioff sold about 15,000 shares of stock for $3.36M.

08:07 EST Grom Social Enterprises signs $8M convertible notes financing agreement - Grom Social Enterprises entered into a securities purchase agreement with a single institutional investor pursuant to which the Company has agreed to sell two convertible promissory notes of the Company. with each Note having an initial principal amount of $4,000,000, for a price of $3,640,000 per Note. In connection with the purchase and sale of the Notes, the Company has agreed to issue to the Investor warrants to acquire a total of 3,028,146 shares of the Company's Common Stock, par value $0.001 per share. The Transactions are subject to shareholder approval. The Company has agreed to secure Shareholder Approval for the SPA and the Transactions at a special meeting or via a written consent in lieu of a meeting. Pursuant to the SPA, the issuance of the Notes and the Warrants shall occur at two closings. The Warrant to be issued at the First Closing shall be a Warrant for 1,514,073 shares of Common Stock and shall have an exercise price of $1.78 per share of Common Stock. The Warrant to be issued at the Second Closing shall be a Warrant for 1,514,073 shares of Common Stock and shall have an exercise price of $0.001 per share of Common Stock. Subject to the terms and conditions set forth in the SPA, the First Closing shall occur on the first business day following the receipt of the Shareholder Approval, and the Second Closing shall occur thirty-five business days following the date that the Registration Statement has been declared effective by the Securities and Exchange Commission/ The shares of Common Stock issuable upon conversion of the Notes and exercise of the Warrants described above have not been registered under the Securities Act of 1933, as amended. They may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to the Registration Rights Agreement, the Company is required to file a registration statement with the SEC covering shares of Common Stock issuable upon conversion of the Notes and exercise of the Warrants. The Company intends to use the net proceeds from the private placement for general working capital and administrative purposes.

08:06 EST GD Culture Group's portfolio company releases patented AI music production tool - GD Culture Group announced that its portfolio company, DigiTrax Entertainment, a music company at the forefront of transforming the music industry by pioneering the use of artificial intelligence solutions, has released its first AI music production software plugin tool, KR38R PRO. The launch heralds the release of a serious of DigiTrax's patented AI-powered products, with a vision to leverage the technology to reshape the future of music, revolutionize music creation, and redefine music experiences. Xiaojian Wang, Chairman and Chief Executive Officer of the Company, commented, "We're proud to announce the launch of DigiTrax's latest product KR38R PRO, which showcasing our commitment to exploring new frontiers in AI-driven technologies. KR38R PRO aims to empower users in today's highly competitive music industry by expediting their creative process. The application of this state-of-the-art technology is expected to have revolutionary impact to the industry, unleashing enormous possibilities and values for artists and labels. The launch of KR38R PRO signifies the start of a series of DigiTrax's patented AI-empowered music technology releases. We anticipate unveiling more products in 2023 and 2024. We believe that this series of products will cater to the needs of established artists, music stakeholders and entertainment technophiles, strengthen the competitiveness of our users in the ever-evolving entertainment industry, and create substantial value for our shareholders."

08:05 EST Cheer Holding announces 1-for-10 share consolidation - Cheer Holding intends to effect a share consolidation of its ordinary shares at a ratio of 1 post-split ordinary share for every 10 pre-split ordinary shares so that every ten shares issued and outstanding will be combined into one share. Any fractional share of a shareholder resulting from the Share Consolidation will be rounded up to the nearest whole number of shares. The Share Consolidation will become effective at 4:05 p.m. on November 24, 2023. The Share Consolidation will be effected by filing a notice to the Registrar of Companies of the Cayman Islands. The Company's ordinary shares will continue to be traded on the Nasdaq Capital Market under the symbol "CHR" and will begin trading on a post-consolidation adjusted basis when the market opens on Monday, November 27, 2023. The CUSIP number for the Company's ordinary shares following the Share Consolidation will be G39973204. The Share Consolidation is primarily intended to increase the Company's per share trading price in order to maintain its listing on Nasdaq. As previously disclosed, on March 22, 2023, the Company received notice from the Listing Qualifications Department of Nasdaq indicating that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Listing Rules. We believe that the proposed Share Consolidation will assist the Company in regaining compliance under the Nasdaq Listing Rules. The Share Consolidation will reduce the issued and outstanding number of ordinary shares of the Company from 100,384,466 shares to approximately 10,038,447 shares. In addition, the Company will be effecting a share increase immediately upon the effectiveness of the Share Consolidation, so as to maintain the same number of authorized ordinary shares before the Share Consolidation, which will continue to be 200,000,000 ordinary shares of a par value of US$0.001.

08:03 EST Kratos Defense, ReLogic enter partnership, form joint venture - Kratos Defense & Rocket Support Solutions, a subsidiary of Kratos Defense & Security Solutions, and ReLogic Research announce the formation of Atreus Technologies, a Small Business Association Mentor Protege Program joint venture. A visionary collaboration between these two companies, Atreus Technologies was created to rapidly and cost effectively deliver leading edge technology and innovation tailored specifically for our valued customers in the defense and aerospace sectors. Atreus Technologies' core objective is to harness the combined strengths of both companies to provide groundbreaking solutions addressing the evolving needs of our Nation's Warfighters. At Kratos, affordability is a technology, and Kratos' leading technology approaches also reduce program and initiative cost, risk and schedule. This methodology will similarly be executed at Atreus. Charles Farmer, Senior Vice President at Kratos, shared his enthusiasm, stating, "I am incredibly excited to embark on this mentor protege joint venture with ReLogic Research. This collaboration represents a significant milestone in our journey, promising a future filled with innovation, mutual growth, and shared success. I am eager to see the remarkable outcomes of this partnership."

07:57 EST McEwen Mining announces flow-through financing - McEwen Mining announced a financing to fund continued exploration and development at the Fox Complex in the Timmins region of Ontario. The proceeds of this financing will be used exclusively for qualifying Canadian Exploration Expenditures and Canadian Development Expenditures within the meaning of subsection 66(15) of the Income Tax Act on McEwen's properties in the Timmins region: Part 1 of the financing consists of a US$7.3 million private placement of 788,000 flow-through common shares at a price of US$9.27; and Part 2 of the financing consists of a US$8.8 million private placement of 1,115,000 flow-through common shares at a price of US$7.86. The Offering of 1,903,000 flow-through common shares for US$16.1 million is expected to close on December 14, 2023 nd is subject to customary closing conditions, including approval from the TSX and NYSE.

07:45 EST SciSparc signs non-binding LOI to merge with vehicle importer company in Israel - SciSparc announced the signing of a non-binding letter of intent to merge with a leading vehicle importer company in Israel. This merger is expected to be consummated by means of a reverse triangular merger, pursuant to which SciSparc will establish a new wholly-owned Israeli subsidiary, which would in turn merge with and into the Target Company, leaving the Target Company as the surviving company. It is contemplated that upon the successful completion of the Merger, SciSparc will transfer its technologies and product candidates pertaining to pharmaceutical activities, with all associated obligations and liabilities, to a separate legal entity. SciSparc will explore the possible distribution of NewCo shares as dividend in kind to its shareholders. The proposed Merger outlines a comprehensive business combination that will result in the Target Company becoming a wholly-owned subsidiary of SciSparc. The proposed Merger follows the Company's announcement in June 2022, in which the board of directors resolved to review potential strategic transactions to maximize shareholder value. Following the closing of the Merger, it is expected that the combined company formed as a result of the Merger will continue to trade on the Nasdaq Capital Market under a new name to be agreed upon by both parties. As a result of the Merger, all outstanding shares of the Target Company will be converted into the right to receive ordinary shares of SciSparc and any warrants issued by the Target Company will be converted into the right to receive warrants of SciSparc, provided however that no equity holder of the Target Company shall beneficially own in excess of 9.99% of the Combined Company's outstanding share capital immediately after the Closing and such equity holder shall be issued pre-funded warrants to purchase ordinary shares of SciSparc in lieu of SciSparc ordinary shares. Following the Closing and the contemplated closing of a concurrent financing round, the Target Company's equity holders will hold approximately 80% of the Combined Company's share capital. In the event that the Target Company secures a direct import license pursuant to which the Target Company sells at least 100 vehicles before 36 months lapse from the date of the Closing, the Target Company equity holders as of the date of the Closing will be entitled to receive additional ordinary shares representing in total 7% of the Combined Company's outstanding share capital immediately following the Closing. Upon Closing, the Combined Company shall transfer an amount of not less than $3 million in cash to the Target Company. The Target Company is a leading vehicle importer in Israel. Its revenues for the first half of 2023 amounted to over $52 million. The Merger is subject to the successful completion of due diligence by both parties, the execution of binding definitive agreements with respect to the Merger and compliance with any regulatory requirements and approvals, including approvals by the shareholders of SciSparc and the Target Company and certain Israeli court approvals.

07:34 EST CTO Realty Growth announces sale of Eastern Commons shopping center for $18.2M - CTO Realty Growth announced the closing of the sale of Eastern Commons, a 129,600 square foot community shopping center located in Henderson, Nevada. The Property was sold for $18.2 million, representing an exit cap rate of 7.4% and generating a gain on sale of approximately $1.7 million. "This transaction, which was our sole property in the Las Vegas market, was another positive step in our efforts to sell our smaller non-core properties. Similar to our other recent dispositions, we are selling non-core properties to pay down debt while we wait for larger format opportunities at attractive values," said John P. Albright, President and Chief Executive Officer of CTO Realty Growth. The Company anticipates utilizing the sales proceeds as part of a Section 1031 like-kind exchange. Following the completion of the 1031 Exchange, the Company intends to use available proceeds to repay a portion of the outstanding balance under its revolving unsecured credit facility. With the closing of this transaction, the Company has approximately $53.7 million of proceeds held in 1031 restricted cash accounts.

07:33 EST Freeline enters agreement to be acquired by Syncona - Freeline Therapeutics announced that it has entered into a definitive agreement with a newly established portfolio company of Syncona to acquire Freeline in an all-cash transaction. Under the agreement, the newly established portfolio company will acquire all shares of Freeline not currently owned by Syncona for $6.50 per American Depositary Share. This price values Freeline's entire issued share capital at approximately $28.3 million and represents a 51% premium over the closing price prior to the announcement of Syncona's initial proposal on October 18. The acquisition is subject to the approval of Freeline's minority shareholders and is expected to close in the first quarter of 2024. In conjunction with the agreement, Syncona is committing to provide Freeline with up to $15 million in secured convertible debt financing to support operations and continued advancement of FLT201, its gene therapy candidate in Gaucher disease, through completion of the transaction. A special committee of the board of directors of Freeline, comprised entirely of independent directors, has unanimously recommended that the minority shareholders vote in favor of the acquisition. It is intended that the acquisition will be implemented by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, whereby the entire issued and to be issued share capital of Freeline will be acquired by a newly established Syncona portfolio company. Further details of the acquisition will be contained in the Scheme Document, which is intended to be made available to Freeline shareholders along with notices of the Court Meeting and General Meeting and the Forms of Proxy as promptly as reasonably practicable following the date Freeline has cleared comments received from the U.S. Securities and Exchange Committee, if any, on such document.

07:31 EST Deere provides FY24 segment outlook - Sees FY24 Production and Precision Ag net sales down 15%-20%, with operating margin 23%-24%; Small Ag & Turf net sales down 10%-15%, with operating margin 15%-16%; Construction and Forestry net sales down about 10%, with operating margin 17%-18%. Sees FY24 Financial Services net income about $770M. Comments taken from Q4 earnings conference call presentation slides.

07:15 EST Docebo CEO Claudio Erba to switch roles, Alessio Artuffo named interim CEO - Docebo announced a CEO succession plan for Claudio Erba, founder of the company. Erba will be stepping away from his role as CEO and a member of the board of directors and will be transitioning to the role of chief innovation officer. The board has appointed Alessio Artuffo to the role of interim CEO effective March 1, 2024. Docebo also announced that the board has approved a substantial issuer bid under which the company will offer to repurchase for cancellation up to $100M of its outstanding common shares at a price of $55.00 per common share.

07:06 EST DavidsTea hires Germilli as Vice-President of Marketing - DAVIDsTEA announced the hiring of Adriana Germilli as Vice-President of Marketing to stimulate demand creation and accelerate sales growth. Germilli previously served as Director of Marketing at DAVIDsTEA from 2016 to 2022.

07:06 EST FCC Chair proposes prohibiting video service 'junk fees' - Federal Communications Commission Chairwoman Jessica Rosenworcel announced a proposal to eliminate video service junk fee billing practices by cable operators and direct broadcast satellite service providers and study their impact on consumer choices. The proposal will be voted on during the December 13 Open Meeting. "No one wants to pay junk fees for something they don't want or can't use. When companies charge customers early termination fees, it limits their freedom to choose the service they want. In an increasingly competitive media market, we should make it easier for Americans to use their purchasing power to promote innovation and expand competition within the industry," said Chairwoman Rosenworcel. Cable and video service operators include Comcast (CMCSA), Charter (CHTR), Dish (DISH) and Altice USA (ATUS). Reference Link

07:04 EST Kontron Merger Sub. extends expiration of tender offer for Bsquare shares - Kontron America, a leader in IoT Technology, and Bsquare jointly announced that Kontron Merger Sub., a wholly owned subsidiary of Kontron, has extended the expiration of its tender offer to acquire all of the outstanding shares of common stock of Bsquare, for $1.90 per Share, net to the seller in cash, without interest and less any applicable withholding taxes, pursuant to the Agreement and Plan of Merger, dated as of October 11 by and among Kontron, Bsquare, and Merger Sub. The Offer has been extended until one minute after 11:59 p.m., Eastern Time, on December 6, unless the Offer is further extended or earlier terminated pursuant to the terms of the Merger Agreement. The Merger Agreement requires that more than 66 2/3% of the sum of the total outstanding Shares at the expiration time of the Offer, plus the total number of Shares that Bsquare is required to issue upon conversion, settlement, exchange or exercise of its convertible securities at the expiration time of the Offer, be tendered in the Offer. The Offer is being extended in order to allow additional time for shareholders of Bsquare to tender their Shares and for Shares tendered by notice of guaranteed delivery to be received to meet this minimum tender condition. The parties do not expect to require additional time for the fulfillment of any other conditions of the Offer. Barnes & Thornburg serves as Kontron's legal advisor. Telegraph Hill BD, the broker-dealer subsidiary of Telegraph Hill Advisors, is acting as financial advisor to Bsquare. DLA Piper serves as Bsquare's legal advisor.

07:03 EST 5E Advanced Metals receives EPA authorization - 5E Advanced Materials confirmed that it has received authorization to begin the in-situ mining process from the Environmental Protection Agency. 5E completed the testing activities focused on extracting boron and lithium as part of its Underground Injection Control permit. The comprehensive testing program ensures that the Company and its 5E Boron Americas Complex are positioned to commence initial operations safely and efficiently. Pursuant to the authorization, 5E will continue to engage with EPA in 2024 to modify its UIC permit to update the permit terms associated with monitoring, modeling, and injection intervals to facilitate long-term injection and operations and maximize boron and lithium extraction. "Our team has worked diligently over the last few years to meet the necessary requirements put forth by the Agency, ensuring that every step aligns with the highest standards of environmental stewardship and operational excellence. I want to thank the entire 5E team for the relentless efforts undertaken to reach this key milestone," said Susan Brennan, Chief Executive Officer of 5E Advanced Materials. "This authorization represents the beginning of an exciting new chapter for our Company as we are now authorized to commence in-situ mining and plant operations at the 5E Boron Americas Complex. We look forward to carrying this momentum forward as we move along our path towards becoming a leading global producer of boric acid and lithium."

07:02 EST GXO Logistics extends partnership with Avon - GXO Logistics, announced that it is extending its agreement with health and beauty industry leader Avon. GXO has supported Avon's operations for 15 years. "We are delighted to extend our longstanding partnership with Avon," said Jean Luc Bessade, GXO Managing Director, Poland, Czech Republic and Romania. "Across our operations, we are proud to support Avon's evolving needs, including helping them adapt to new regulations in their markets and providing co-packing and value-added services. Through our high-quality service and our open communications and cooperation, we've been able to grow our business with Avon over many years. We very much look forward to expanding and continuously enhancing our partnership."

06:58 EST Deere sees FY24 net income $7.75B-$8.25B - "While our end markets will fluctuate, we remain focused on disciplined execution and strategically investing in solutions that drive customer value," May said. "As evidenced by our guidance for 2024, we are demonstrating higher levels of through-cycle structural profitability while making our company more resilient and better equipped for the future."

06:11 EST Blackstone to acquire Civica, terms not disclosed. - Blackstone announced that private equity funds managed by affiliates of Blackstone have entered into a definitive agreement to acquire Civica, a global leader in public sector software solutions, from Partners Group, a leading global private markets firm, acting on behalf of its clients. Financial terms of the transaction were not disclosed. The transaction is expected to close in Q2 2024, subject to regulatory approvals. "Civica is a leader in the 'GovTech' space, with an excellent brand and an enviable market position and we are excited to be partnering with a stellar management team to help the business in this next phase of growth. This investment is a testament to our long-standing software experience, a significant focus area for the firm globally, and builds on our strong track record of investing here in the UK," said Jonathan Murphy, a Managing Director at Blackstone and Miguel Garcia Gomez, a Principal at Blackstone. Reference Link

06:01 EST Valneva announces FDA approval of Ixciq - The FDA announced the approval of Ixciq, Valneva's vaccine against the chikungunya virus. Notably, this is the first vaccine against the mosquito-borne disease to have been granted marketing approval by the FDA.

05:44 EST Fresenius Medical enters into settlement agreement with U.S. government - Fresenius Medical Care on Tuesday announced that it resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement, whereby the company will receive a payment from the U.S. government. Fresenius Medical Care had filed a complaint against the United States in 2019. This complaint sought to recover monies owed to the company by the U. S. Department of Defense under the Tricare program, for services on or before January 11, 2023. The now executed settlement agreement resolves the dispute underlying the complaint and concludes the litigation. As a consequence of the settlement agreement, both revenue and operating income will be positively impacted. Fresenius Medical Care therefore expects a net positive impact on operating income of approx. EUR 175 million in the fourth quarter 2023. The company had previously expected in fiscal year 2023 operating income to grow by a low-single-digit percentage rate, compared to previous year. As a consequence of the settlement agreement, Fresenius Medical Care today raises its earnings outlook. The company now expects operating income to grow by 12%-14% in fiscal year 2023, compared to previous year. All other elements of the 2023 outlook, as published, remain unchanged. In line with its disciplined financial policy, Fresenius Medical Care intends to use the agreed settlement payment to reduce its net financial debt and therefore deleverage the balance sheet. Reference Link

05:39 EST Infosys enters long-term collaboration with TK Elevator - Infosys announced a strategic long-term collaboration with TK Elevator. As a part of the engagement, Infosys will consolidate, harmonize, and modernize TK Elevator's digital landscape. The two companies will work together to transition the operations of all TK Elevator's business applications across North America and major markets in Europe to Infosys, thereby enabling integrated applications management.